Last updated: 2026-10-19 22:57:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
iRadimed Corporation (IRMD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $87.51, with a market capitalization of $1.13B and a P/E ratio of 48.96. Over the past 52 weeks, its price has ranged from $73.25 to $107.90. This page covers its latest market performance, valuation, price trends and company information.
$1.13B | |
$88.48 | |
$107.90 | |
$6.26 | |
$88.27 | |
67.06K | |
122.77K | |
48.96 | |
$107.90 | |
$73.25 | |
1.40% | |
-- |
iRadimed Corporation (IRMD) is trading at $87.66 in after-hours trading as of 2026-10-19 22:18:00, down 0.69% ($0.61) from the regular-session close of $88.27.
After-hours trading shows how investors are pricing IRMD after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, iRadimed Corporation (IRMD) moved from $85.88 to $87.51, representing a gain of 1.89% ($1.63).
The stock traded between $84.58 and $91.05 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 86.09 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 41.1%
IRMD is currently trading at $87.51, placing it 41.1% of the way from its 52-week low of $73.25 to its 52-week high of $107.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 166 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of iRadimed Corporation (IRMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.